JNK-2 silencing with focally acting peptide-siRNA nanostructures modulates plaque inflammation in atherosclerotic mice

26 August 2018 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Inflammation and vascular disease Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis ESC Premium Access ESC Congress 2018

ESC 365 is supported by

ESC 365 is supported by